CLAIM #50255 · PM (PM) · 2025Q1 earnings call · Apr 23, 2025 · due Dec 31, 2026
“As expected, input cost headwinds eased compared to recent years and based on current assumption, we expect this to further improve in 2026.”
Emmanuel Babeau · CFO
How to check this claim
Look at: Input cost headwind impact on gross margin/cost of goods sold, as described in company commentary (organic currency-neutral basis)
It came true if: Company reports further easing/improvement of input cost headwinds in 2026 versus 2025 (directional: favorable input cost commentary or margin benefit attributed to input costs in FY2026 disclosures)
Where: Company management commentary on input costs (quarterly earnings calls / press releases, FY2026)
In context
“tive unit economics and pricing on both HTUs and ZYN. Very strong IQOS gross margin expansion reflects the powerful growth and scale effect of this large and growing business, manufacturing productivity, and a comparison benefit from higher device shipment in the prior year when ILUMA i was launched in Japan. On an organic basis, combustible net revenues and gross profit grew by plus 3.8% and plus 5.3% respectively. While pricing was strong and volume were positive, there was a notably negative geographic mix this quarter due to growth in markets such as Turkey and Egypt, in addition to the technical impact from Indonesia. We expect gross pricing and negative geographic mix to moderate over the rest of the year and target combustible gross margin expansion organically and in dollar terms. As expected, input cost headwinds eased compared to recent years and based on current assumption, we expect this to further improve in 2026. Taking a closer look at our volumes, shipment growth of plus 3.9% was primarily driven by our smoke-free business with all categories contributing positively and placing us on track for a fifth consecutive year of total volume growth. Smoke-free volumes grew by plus 14.4%, above our full year target range of plus 12% to plus 14%, reflecting very positive contribution from IQOS, ZYN, and VEEV. In addition to the growth of these three brands, which I covered earlier, I would also note that our oral smoke-free business includes US Moist Snuff and Scandinavian Snus, which declined modestly in the quarter. Despite this, oral smoke-free product shipment growth accelerated versus the prior quarter to plus 27%. Cigarette volumes were positive for the fourth consecutive quarter as we grew share in”
Verify independently
SEC filings for PM ↗ · Claim quote is verbatim from the 2025Q1 earnings call.